drugset / Trial / NCT02590536

A Trial Evaluating the Role of Sildenafil in the Treatment of Fetal Growth Restriction

NCT02590536

Phase 3 Completed 90 enrolled Ain Shams University
RandomizedParallel-groupSingle-blindTreatment

Summary

This is a Randomized Controlled Trial to evaluate the effect of sildenafil on Doppler velocity indices of the umbilical arteries in patients with placental insufficiency and fetal growth restriction, and if sildenafil can improve fetal and neonatal outcomes in those patients.

Timeline

Start
2015-10
Primary completion
2017-06
Completion
2017-06-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown 25 mg Oral